These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24000508)

  • 1. Influence of pharmaceutical marketing on prescription practices of physicians.
    Narendran R; Narendranathan M
    J Indian Med Assoc; 2013 Jan; 111(1):47-50. PubMed ID: 24000508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The high cost of free lunch.
    Wall LL; Brown D
    Obstet Gynecol; 2007 Jul; 110(1):169-73. PubMed ID: 17601912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The medical profession and the pharmaceutical industry: when will we open our eyes?
    Breen KJ
    Med J Aust; 2004 Apr; 180(8):409-10. PubMed ID: 15089732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perception of prescription medicine sample packs among Australian professional, government, industry, and consumer organizations, based on automated textual analysis of one-on-one interviews.
    Kyle GJ; Nissen L; Tett S
    Clin Ther; 2008 Dec; 30(12):2461-73. PubMed ID: 19167604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "But doctors do it...": nurses' views of gifts and information from the pharmaceutical industry.
    Jutel A; Menkes DB
    Ann Pharmacother; 2009 Jun; 43(6):1057-63. PubMed ID: 19470854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical company influences on medication prescribing and their potential impact on quality use of medicines.
    Kyle GJ; Nissen LM; Tett SE
    J Clin Pharm Ther; 2008 Oct; 33(5):553-9. PubMed ID: 18834371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient awareness and concern regarding pharmaceutical manufacturer interactions with doctors.
    Edwards D; Ballantyne A
    Intern Med J; 2009 Mar; 39(3):191-6. PubMed ID: 19383067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceptions of the influence of prescription medicine samples on prescribing by family physicians.
    Hall KB; Tett SE; Nissen LM
    Med Care; 2006 Apr; 44(4):383-7. PubMed ID: 16565641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does brand differentiate pharmaceuticals?
    Bednarik J
    Neuro Endocrinol Lett; 2005 Dec; 26(6):635-52. PubMed ID: 16380705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of a mandatory guideline that prohibit hospital doctors from accepting any form of benefits in any form from the pharmaceutical industry].
    Gundermann C; Meier-Hellmann A; Bauer M; Hartmann M
    Dtsch Med Wochenschr; 2010 May; 135(3):67-70. PubMed ID: 20077378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical marketing strategies' influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples.
    Khazzaka M
    BMC Health Serv Res; 2019 Jan; 19(1):80. PubMed ID: 30700295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why lunch matters: assessing physicians' perceptions about industry relationships.
    Fugh-Berman AJ; Scialli AR; Bell AM
    J Contin Educ Health Prof; 2010; 30(3):197-204. PubMed ID: 20872775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The assessment of pharmaceutical sales representatives by family physicians--does it affect the prescribing index?
    Klemenc-Ketis Z; Kersnik J
    Fam Pract; 2013 Jun; 30(3):320-4. PubMed ID: 23241163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric responsiveness of physician prescription behavior to drug promotion of competitive brands within an established therapeutic drug class.
    Pedan A; Wu H
    Health Mark Q; 2011 Apr; 28(2):133-54. PubMed ID: 21590561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of services provided by pharmaceutical companies: perceptions of physicians and pharmaceutical sales representatives.
    Gaedeke RM; Tootelian DH; Sanders EE
    Health Mark Q; 1999; 17(1):23-31. PubMed ID: 11066720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct marketing of pharmaceuticals to consumers.
    Lyles A
    Annu Rev Public Health; 2002; 23():73-91. PubMed ID: 11910055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nurse practitioners' perceptions and participation in pharmaceutical marketing.
    Crigger N; Barnes K; Junko A; Rahal S; Sheek C
    J Adv Nurs; 2009 Mar; 65(3):525-33. PubMed ID: 19222650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicians, the industry and population health.
    Gérvas J; Mansfield PR
    J Epidemiol Community Health; 2009 Oct; 63(10):773-4. PubMed ID: 19749125
    [No Abstract]   [Full Text] [Related]  

  • 20. What do Libyan doctors perceive as the benefits, ethical issues and influences of their interactions with pharmaceutical company representatives?
    Alssageer MA; Kowalski SR
    Pan Afr Med J; 2013; 14():132. PubMed ID: 23734277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.